H.R. 2338 · 114th Congress
To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
- Stage
- In committee
- Sponsor
- Joseph Pitts
- Introduced
- 2015-05-14
- Latest action
- 2015-05-15 · Referred to the Subcommittee on Health.
Votes
No linked votes are available for this bill.